Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Practices encouraged to speak to rabbit owners about RVHD2
rabbit
Vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with.

Disease is now geographically widespread in the UK

Veterinary organisations have issued advice to practices on a new strain of Rabbit Viral Haemorrhagic Disease.

As the spread of RVHD2 may be facilitated by its apparent progression, compared to RVHD1, the BVA, BSAVA and BVZA recommend practices talk to owners about preventing this potentially devastating disease.

In a joint statement, they write: 'Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease.

'Further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.'

RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices) to a longer disease course of three to nine days. 

This longer disease course increases the risk of sick rabbits being brought into practices and, in turn, increases the risk of transmission to other pet rabbits.

Vaccines for the original strain of RVHD1 do not offer long term protection against RVHD2. However, vaccines for this new strain are now available in the UK. These can be purchased from Centaur, NVS and Henry Schein Animal Health.

John Chitty, BSAVA vice president, said: “BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2.”

BVZS president Mark Stidworthy adds: “It is clear from post-mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.